Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combined 18F-Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) and Metomidate Imaging for Adrenal Neoplasia (FAMIAN-Study) - a Diagnostic Study

NCT02010957 is registered in ClinicalTrials.gov with Wuerzburg University Hospital as lead sponsor.

NCT NCT02010957
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02010957 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combined 18F-Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) and Metomidate Imaging for Adrenal Neoplasia (FAMIAN-Study) - a Diagnostic Study
Lead sponsor
Wuerzburg University Hospital
Phase
Phase 3
Overall status
Terminated
Start date
July 31, 2015
Completion date
July 31, 2022
Enrollment
85 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

adrenal neoplasia